Cargando…
Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
Since decades, lithium and valproate remain the pharmacological cornerstone to treat bipolar disorder. Different response patterns occur according to the phases of illness. At same time, individual pretreatment variables may concur to determine a specific drug-response. Our narrative review focuses...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean College of Neuropsychopharmacology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329114/ https://www.ncbi.nlm.nih.gov/pubmed/35879025 http://dx.doi.org/10.9758/cpn.2022.20.3.403 |